Filer Snapshot

NEXTHERA CAPITAL LP

CIK 0001646343. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity Type

Company

Total Filings

26

Latest Filing

14 Aug 2019

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: 13F-HR for Q2 2019. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Latest 13F portfolio

$120.06M

23 holdings for Q2 2019

Open portfolio

Largest parsed holding

ICPT

$12.13M reported value

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Form 13F

13F-HR filed on 14 Aug 2019 for CIK 0001646343.

View Source Filing
Identity
Business address
900 Third Avenue, Suite 201 2, New York, NY, 10022
SEC ownership signals
Filing-backed coverage

13F portfolio value

$120.06M

Latest parsed institutional portfolio value.

Top 13F symbols

ICPT, INSM, BOLD, NBIX

Symbols from the latest parsed 13F holdings.

SEC record
State of incorporation
DE
Fiscal year end
31 December

Filer intelligence

What SEC filings say about NEXTHERA CAPITAL LP

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Latest parsed 13F shows $120.06M across 23 reported holdings for Q2 2019.
  • Largest parsed 13F holding: ICPT at $12.13M.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio 23 rows

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 No rows yet

Officer, director, and 10% owner holdings or transactions.

Open

Top parsed 13F holdings

Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.

Q2 2019 - 14 Aug 2019

Top 5 concentration

42%

Share of latest parsed 13F value represented by the visible holdings below.

Top 5 reported value

$50.76M

Compared with $120.06M total 13F value.

Top 5 net change

+$27.78M

Position-value change inside the visible top holdings only.

13F concentration map

A simple visual split of the latest parsed 13F portfolio.

Largest add: ICPT ยท Largest trim: HRTX

ICPT INSM BOLD NBIX SRPT Other holdings

ICPT

10.1%

Intercept Pharmaceuticals Inc

$12.13M

INSM

10%

Insmed Inc

$12.05M

BOLD

9.3%

Audentes Therapeutics Inc

$11.13M

NBIX

6.5%

Neurocrine Biosciences Inc

$7.8M

SRPT

6.4%

Sarepta Therapeutics Inc

$7.65M

Latest update

What changed recently for NEXTHERA CAPITAL LP

New filing available

Latest 13F period: Q2 2019. Open the source-backed page to inspect the fresh filing or facts context.

Update date

14 Aug 2019

Page type

Filer profile

Latest period

Q2 2019

Institutional portfolio context was refreshed from a 13F filing filed on 14 Aug 2019.

Benchmark Context

Benchmark context for this company

NEXTHERA CAPITAL LP has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest 13F period: Q2 2019. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

SEC filing record

CIK 0001646343 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
26
First seen
16 Feb 2016
Latest filing
14 Aug 2019
Entity
Company

Observed form types

13F-HR SC 13G/A SC 13G

Latest Filings

Showing the latest 12 of 26 SEC filings for NEXTHERA CAPITAL LP.

13F-HR File 028-17280

13F-HR filing

Filing date
14 Aug 2019
Reporting date
30 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-17280

13F-HR filing

Filing date
15 May 2019
Reporting date
31 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-17280

13F-HR filing

Filing date
14 Feb 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

FEBRUARY 14, 2019

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

FEBRUARY 14, 2019

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

FEBRUARY 14, 2019

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

NOVEMBER 26, 2018

Filing date
26 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-17280

13F-HR filing

Filing date
14 Nov 2018
Reporting date
30 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-17280

13F-HR filing

Filing date
14 Aug 2018
Reporting date
30 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

JUNE 6, 2018

Filing date
11 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

MAY 24, 2018

Filing date
24 May 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-17280

13F-HR filing

Filing date
15 May 2018
Reporting date
31 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .